EFG International AG purchased a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 119,627 shares of the company’s stock, valued at approximately $15,364,000.
A number of other hedge funds have also modified their holdings of the stock. Frazier Financial Advisors LLC acquired a new stake in shares of Merck KGaA during the second quarter worth $25,000. Rakuten Securities Inc. purchased a new position in Merck KGaA in the 2nd quarter worth about $27,000. Solstein Capital LLC acquired a new stake in Merck KGaA during the 2nd quarter worth about $33,000. Delos Wealth Advisors LLC purchased a new stake in Merck KGaA during the second quarter valued at about $33,000. Finally, Burk Holdings LLC acquired a new position in shares of Merck KGaA in the second quarter worth about $39,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.
Merck KGaA Stock Performance
Merck KGaA stock opened at $164.00 on Wednesday. Merck KGaA has a fifty-two week low of $116.68 and a fifty-two week high of $175.56. The firm’s 50 day simple moving average is $163.08 and its 200-day simple moving average is $148.69. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The company has a market cap of $21.20 billion, a P/E ratio of 25.04 and a beta of 0.96.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
